Literature DB >> 1384266

Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes.

M Mercken1, M Vandermeeren, U Lübke, J Six, J Boons, A Van de Voorde, J J Martin, J Gheuens.   

Abstract

A modified form of the microtubule-associated protein Tau is the major component of the paired helical filaments (PHF) found in Alzheimer's disease. The characterization of these posttranslational Tau modifications is hindered by the lack of sufficient PHF-Tau-specific markers. Here we describe several monoclonal antibodies, prepared by immunization with PHF, two of which showed a selective specificity for PHF-Tau without cross-reactivity with normal Tau. Epitope recognition by these two monoclonals was sensitive to alkaline phosphatase treatment. In Western blotting these monoclonal antibodies reacted specifically with the abnormally phosphorylated epitopes on Alzheimer's disease-associated PHF-Tau. One of the new antibodies can be used for the construction of a sandwich enzyme-linked immunosorbent assay for the specific detection of PHF-Tau without cross-reactivity to normal Tau proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384266     DOI: 10.1007/bf00227819

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

1.  Tau marker?

Authors:  S Flament; A Delacourte
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

2.  Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection.

Authors:  M Mercken; M Vandermeeren; U Lübke; J Six; J Boons; E Vanmechelen; A Van de Voorde; J Gheuens
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

3.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases.

Authors:  J Gheuens; P Cras; G Perry; J Boons; C Ceuterick-de Groote; U Lübke; M Mercken; M Tabaton; P L Gambetti; M Vandermeeren
Journal:  Brain Res       Date:  1991-08-30       Impact factor: 3.252

7.  Phosphorylation characteristics of the A68 protein in Alzheimer's disease.

Authors:  I J Vincent; P Davies
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

8.  Specific monoclonal antibodies against normal microtubule-associated protein-2 (MAP2) epitopes present in Alzheimer pathological structures do not recognize paired helical filaments.

Authors:  J Six; U Lübke; M Mercken; M Vandermeeren; C Ceuterick; A Van de Voorde; J Boons; J Gheuens
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.

Authors:  J P Brion; D P Hanger; M T Bruce; A M Couck; J Flament-Durand; B H Anderton
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  89 in total

1.  Both total and phosphorylated tau are increased in Alzheimer's disease.

Authors:  M Sjögren; P Davidsson; M Tullberg; L Minthon; A Wallin; C Wikkelso; A K Granérus; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

2.  Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells.

Authors:  P K Davis; G V Johnson
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

4.  Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.

Authors:  Sabine Ott; Andreas Wolfram Henkel; Maria Kerstin Henkel; Zoran B Redzic; Johannes Kornhuber; Jens Wiltfang
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

5.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.

Authors:  David J Irwin; Alberto Lleó; Sharon X Xie; Corey T McMillan; David A Wolk; Edward B Lee; Viviana M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

8.  Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease.

Authors:  Sami Ridwan; Henrike Bauer; Katrin Frauenknecht; Kyra Hefti; Harald von Pein; Clemens J Sommer
Journal:  J Anat       Date:  2014-01-05       Impact factor: 2.610

Review 9.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

10.  Neuropathologic substrates of Parkinson disease dementia.

Authors:  David J Irwin; Matthew T White; Jon B Toledo; Sharon X Xie; John L Robinson; Vivianna Van Deerlin; Virginia M-Y Lee; James B Leverenz; Thomas J Montine; John E Duda; Howard I Hurtig; John Q Trojanowski
Journal:  Ann Neurol       Date:  2012-10-04       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.